After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Shares of Regeneron Pharmaceuticals were lower Monday after The Food and Drug Administration put a drug study on hold.
Don't focus on just one day of trading, Jim Cramer says.
On days like this, the money just keeps sloshing around.
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.